Wei Xiao-Qian, Zhang Yang-Min, Sun Yu, Ling Hua-Yu, He Yuan-Ning, Fu Jin-Xiang
Department of Hematology, The Second Affiliated Hospital of Soochow University, Suzhou 215004, Jiangsu Province, China.
Department of Hematology, The Second Affiliated Hospital of Soochow University, Suzhou 215004, Jiangsu Province, China.E-mail:
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023 Feb;31(1):154-161. doi: 10.19746/j.cnki.issn.1009-2137.2023.01.025.
To investigate the effect of adipocytes in the bone marrow microenvironment of patients with multiple myeloma (MM) on the pathogenesis of MM.
Bone marrow adipocytes (BMA) in bone marrow smears of health donors (HD) and newly diagnosed MM (ND-MM) patients were evaluated with oil red O staining. The mesenchymal stem cells (MSC) from HD and ND-MM patients were isolated, and in vitro co-culture assay was used to explore the effects of MM cells on the adipogenic differentiation of MSC and the role of BMA in the survival and drug resistance of MM cells. The expression of adipogenic/osteogenic differentiation-related genes , , , , and both in MSC and MSC-derived adipocytes was determined with real-time quantitative PCR. The Western blot was employed to detect the expression levels of IL-6, IL-10, SDF-1α, TNF-α and IGF-1 in the supernatant with or without inhibitor.
The results of oil red O staining of bone marrow smears showed that BMA increased significantly in patients of ND-MM compared with the normal control group, and the BMA content was related to the disease status. The content of BMA decreased in the patients with effective chemotherapy. MM cells up-regulated the expression of MSC adipogenic differentiation-related genes , , , and , but the expression of osteogenic differentiation-related gene was significantly down-regulated. This means that the direct consequence of the interaction between MM cells and MSC in the bone marrow microenvironment is to promote the differentiation of MSC into adipocytes at the expense of osteoblasts, and the cytokines detected in supernatant changed. inhibitor G3335 could partially reverse the release of cytokines by BMA. Those results confirmed that BMA regulated the release of cytokines via signal, and inhibitor G3335 could distort mediated BMA maturation and cytokines release. The increased BMA and related cytokines effectively promoted the proliferation, migration and drug resistance of MM cells.
The BMA and its associated cytokines are the promoting factors in the survival, proliferation and migration of MM cells. BMA can protect MM cells from drug-induced apoptosis and plays an important role in MM treatment failure and disease progression.
探讨多发性骨髓瘤(MM)患者骨髓微环境中的脂肪细胞对MM发病机制的影响。
采用油红O染色评估健康供者(HD)和新诊断MM(ND-MM)患者骨髓涂片中的骨髓脂肪细胞(BMA)。分离HD和ND-MM患者的间充质干细胞(MSC),采用体外共培养试验探讨MM细胞对MSC成脂分化的影响以及BMA在MM细胞存活和耐药中的作用。通过实时定量PCR检测MSC和MSC来源的脂肪细胞中成脂/成骨分化相关基因 、 、 、 、 和 的表达。采用蛋白质免疫印迹法检测有或无 抑制剂时上清液中IL-6、IL-10、SDF-1α、TNF-α和IGF-1的表达水平。
骨髓涂片油红O染色结果显示,与正常对照组相比,ND-MM患者的BMA显著增加,且BMA含量与疾病状态相关。化疗有效的患者BMA含量降低。MM细胞上调了MSC成脂分化相关基因 、 、 、 和 的表达,但成骨分化相关基因 的表达显著下调。这意味着骨髓微环境中MM细胞与MSC相互作用的直接后果是以成骨细胞为代价促进MSC向脂肪细胞分化,且上清液中检测到的细胞因子发生了变化。 抑制剂G3335可部分逆转BMA释放细胞因子的情况。这些结果证实BMA通过 信号调节细胞因子的释放, 抑制剂G3335可破坏 介导的BMA成熟和细胞因子释放。BMA及相关细胞因子增加有效促进了MM细胞的增殖、迁移和耐药性。
BMA及其相关细胞因子是MM细胞存活、增殖和迁移的促进因素。BMA可保护MM细胞免受药物诱导的凋亡,在MM治疗失败和疾病进展中起重要作用。